Medical Xpress In a recent study, researchers bound the most clinically-used growth factor with microparticles of the drug heparin at concentrations up to 1,000-fold higher than previously reported. The growth factor, called bone morphogenetic protein-2 (BMP-2), also ... and more »
HealthCanal.com Las Vegas, Nev. — Two new studies that compared the safety and effectiveness of heparin and bivalirudin in percutaneous coronary intervention (PCI) will add fuel to the recent debate about the relative merits of the two anticoagulation medications, ...
TCTMD PARIS, France—In patients with ST-segment myocardial infarction (STEMI) being transported for primary percutaneous coronary intervention (PCI), upstream bivalirudin lowers mortality or major bleeding compared with heparin , an advantage that is ...
Azom.com In a recent study, researchers bound the most clinically-used growth factor with microparticles of the drug heparin at concentrations up to 1,000-fold higher than previously reported. The growth factor, called bone morphogenetic protein-2 (BMP-2), also ...
Healio LAS VEGAS — Two studies presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions came to different conclusions on whether bivalirudin or heparin produces better outcomes in patients undergoing PCI. One study ...
